Fluoroquinolone Can Be an Effective Treatment Option for Acute Pyelonephritis When the Minimum Inhibitory Concentration of Levofloxacin for the Causative Escherichia coli Is ≤16 mg/L

The purpose of this study was to determine whether the fluoroquinolone (FQ) minimum inhibitory concentration (MIC) for the causative agent Escherichia coli influences the clinical response of FQ treatment at 72 h in patients with community-acquired acute pyelonephritis (CA-APN). We prospectively col...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antibiotics (Basel)
Autors principals: Kim, Yeonjae, Kim, Bongyoung, Wie, Seong Heon, Kim, Jieun, Ki, Moran, Cho, Yong Kyun, Lim, Seung Kwan, Lee, Jin Seo, Kwon, Ki Tae, Lee, Hyuck, Cheong, Hee Jin, Park, Dae Won, Ryu, Seong Yeol, Chung, Moon Hyun, Pai, Hyunjoo
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7823373/
https://ncbi.nlm.nih.gov/pubmed/33401660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10010037
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars